Kirazli S - Search Results

1

Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?

Erman M, Abali H, Oran B, Haznedaroglu IC, Canpinar H, Kirazli S, Celik I. Erman M, et al. Among authors: kirazli s. Ann Oncol. 2004 Nov;15(11):1622-6. doi: 10.1093/annonc/mdh437. Ann Oncol. 2004. PMID: 15520062 Free article. Clinical Trial.

2

Local fibrinolysis in native arteriovenous fistulas of haemodialysis patients.

Haznedaroğlu IC, Erdem Y, Celik I, Sayinalp NM, Dündar SV, Cağlar S, Kirazli S. Haznedaroğlu IC, et al. Among authors: kirazli s. Blood Purif. 1996;14(3):227-33. doi: 10.1159/000170265. Blood Purif. 1996. PMID: 8738536

3

Impaired haemostatic kinetics and endothelial function in Behçet's disease.

Haznedaroglu IC, Ozcebe OI, Ozdemir O, Celik I, Dündar SV, Kirazli S. Haznedaroglu IC, et al. Among authors: kirazli s. J Intern Med. 1996 Oct;240(4):181-7. doi: 10.1046/j.1365-2796.1996.396853000.x. J Intern Med. 1996. PMID: 8918508

4

Tissue factor pathway inhibitor concentrations in cirrhotic patients with and without portal vein thrombosis.

Oksüzoğlu G, Simsek H, Haznedaroğlu IC, Kirazli S. Oksüzoğlu G, et al. Among authors: kirazli s. Am J Gastroenterol. 1997 Feb;92(2):303-6. Am J Gastroenterol. 1997. PMID: 9040211

5

Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state.

Kiraz S, Ertenli I, Benekli M, Haznedaroğlu IC, Calgüneri M, Celik I, Apraş S, Kirazli S. Kiraz S, et al. Among authors: kirazli s. Lupus. 1999;8(9):737-41. doi: 10.1191/096120399678840918. Lupus. 1999. PMID: 10602446

6

Plasma fibronectin- and thrombospondin-adhesive molecules during acute attacks and attack-free periods of familial Mediterranean fever.

Ertenli I, Kiraz S, Oztürk MA, Haznedaroglu IC, Celik I, Kirazli S, Calgüneri M. Ertenli I, et al. Among authors: kirazli s. Rheumatol Int. 2001 Aug;20(6):217-20. doi: 10.1007/s002960100107. Rheumatol Int. 2001. PMID: 11563578

7

Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic state.

Ertenli I, Kiraz S, Celik IC, Haznedaroglu C, Erman M, Calgüneri M, Kirazli S. Ertenli I, et al. Among authors: kirazli s. Ann Rheum Dis. 2001 Dec;60(12):1149-51. doi: 10.1136/ard.60.12.1149. Ann Rheum Dis. 2001. PMID: 11709459 Free PMC article.

8

P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.

Ertenli I, Kiraz S, Arici M, Haznedaroglu IC, Calgüneri M, Celik I, Kirazli S. Ertenli I, et al. Among authors: kirazli s. J Rheumatol. 1998 Jun;25(6):1054-8. J Rheumatol. 1998. PMID: 9632062

9

Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.

Kiraz S, Ertenli I, Arici M, Calgüneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S. Kiraz S, et al. Among authors: kirazli s. Clin Exp Rheumatol. 1998 Nov-Dec;16(6):721-4. Clin Exp Rheumatol. 1998. PMID: 9844766 Clinical Trial.

10

Circulating thrombomodulin, thrombospondin, and fibronectin in acute myeloblastic leukemias.

Ozatli D, Koçoğlu H, Haznedaroğlu IC, Koşar A, Büyükaşik Y, Ozcebe O, Kirazli S, Dündar SV. Ozatli D, et al. Among authors: kirazli s. Haematologia (Budap). 1999;29(4):277-83. Haematologia (Budap). 1999. PMID: 10438067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters